IceCure Highlights Clinical Data and Strong Physician Engagement for ProSense® Breast Cancer Cryoablation at EUSOBI 2026
Go back to IceCure Highlights Clinical Data and Strong Physician Engagement for ProSense® Breast Cancer Cryoablation at EUSOBI 2026| (NASDAQ: ICCM) | Delayed: 1.02 -0.06 (5.56%) | |||||
|---|---|---|---|---|---|---|
| Previous Close | $1.08 | 52 Week High | $ | |||
| Open | $1.06 | 52 Week Low | $ | |||
| Day High | $1.12 | P/E | N/A | |||
| Day Low | $1.01 | EPS | $ | |||
| Volume | 167,127 | |||||



